SUSTAIN-6 (semaglutide) showed acute pancreatitis in 0.3% of semaglutide patients versus 0.2% of placebo patients
Antidiabetic properties of berberine: from cellular pharmacology to clinical effects
Liraglutide in an adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12-17 years
GLP-1 analog treatment in the failed gastric bypass patient
For GLP-1 users specifically , connecting with others who understand the unique experience of using these medications can be invaluable
For some, they feel like a breakthrough after years of struggling with blood sugar issues, metabolic dysfunction, or weight gain despite dieting and other approaches